Ying Du
Chief Executive Officer chez ZAI LAB LIMITED
Fortune : 2 M $ au 31/03/2024
Postes actifs de Ying Du
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ZAI LAB LIMITED | Chief Executive Officer | 01/04/2014 | - |
| Chairman | 01/04/2014 | - | |
| Founder | 01/04/2014 | - | |
| JHL BIOTECH, INC. | Director/Board Member | 17/12/2012 | - |
Zai Venture Partners
 Zai Venture Partners Investment ManagersFinance Zai Venture Partner is a venture capital investment firm. The firm is headquartered in Cayman Islands. It is founded by Ying Samantha Du in 2017. | Founder | 01/01/2017 | - |
| Private Equity Investor | 01/01/2017 | - |
Historique de carrière de Ying Du
Anciens postes connus de Ying Du
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Hongshan
 Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | Private Equity Investor | - | - |
Hutchison Whampoa (China) Ltd.
 Hutchison Whampoa (China) Ltd. Financial ConglomeratesFinance Part of CK Hutchison Holdings Ltd., Hutchison Whampoa (China) Ltd. is a Chinese company that provides investment services. The private company is based in Hong Kong, Hong Kong. Chi Keung To has been the CEO of the company since 1980. | Corporate Officer/Principal | 01/01/2001 | - |
| HUTCHMED (CHINA) LIMITED | Chief Tech/Sci/R&D Officer | 12/09/2011 | - |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Chief Executive Officer | 01/06/2002 | - |
| Founder | 24/03/2010 | - |
Formation de Ying Du
| University of Cincinnati (Ohio) | Doctorate Degree |
| Jilin University | Undergraduate Degree |
Statistiques
Internationale
| Chine | 5 |
| Hong Kong | 3 |
| Etats-Unis | 2 |
Opérationnelle
| Founder | 3 |
| Chief Executive Officer | 2 |
| Private Equity Investor | 2 |
Sectorielle
| Health Technology | 5 |
| Finance | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HUTCHMED (CHINA) LIMITED | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| Entreprise privées | 5 |
|---|---|
Hutchison Whampoa (China) Ltd.
Hutchison Whampoa (China) Ltd. Financial ConglomeratesFinance Part of CK Hutchison Holdings Ltd., Hutchison Whampoa (China) Ltd. is a Chinese company that provides investment services. The private company is based in Hong Kong, Hong Kong. Chi Keung To has been the CEO of the company since 1980. | Finance |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | Finance |
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
Zai Venture Partners
Zai Venture Partners Investment ManagersFinance Zai Venture Partner is a venture capital investment firm. The firm is headquartered in Cayman Islands. It is founded by Ying Samantha Du in 2017. | Finance |
